Soy isoflavones also showed inhibitory effects on the ER-negative MDA-MB-231 breast cancer cells [62,63], indicating that apart from interacting with ER, soy isoflavones also exert anti-breast cancer effect through various ER-independent mechanisms. This evidence concerns the gene ESR1 and breast carcinoma.